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Mycobacteria are the strong stimulators of respiratory burst, resulting in production of
reactive oxygen species and nitrogen intermediates.
The aim of our study was to assess the concentration of hydrogen peroxide (H2O2) in
expired breath condensate (EBC) and the serum level of interleukin-18 (IL-18) in patients
with active pulmonary tuberculosis (TB) before introduction of chemotherapy and after 2
months of treatment.
Sixteen patients, current cigarette smokers, with advanced pulmonary TB were enrolled
into the study. As a control served two groups: I group—16 asymptomatic cigarette
smokers, II group—17 healthy never smoked subjects. The level of H2O2 in EBC was
significantly higher in patients with TB (1.370.7mM) as compared to cigarette are healthy
nonsmoker subjects (0.470.1 and 0.270.1 mM, respectively, Po0.05). Two months of
treatment significantly decreased the level of H2O2 exhalation in TB patients (0.570.3 mM)
to the value that was not different from that in asymptomatic smokers but was still higher
than in never smoked subjects. Serum concentration of IL-18 in TB patients was higher
than that found in both control groups either before and after antituberculous treatment
(Po0:05). Exhaled H2O2 did not correlate with circulating IL-18 in TB patients before or
after treatment.
These results demonstrated the occurrence of oxidative stress in the airways of TB patients
completely attenuating after 2 months of successful antituberculous treatment.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Kwiatkowska).Introduction
At the embarkation of the 21st century, tuberculosis (TB)
persist as one of the major causes of death from a single
infectious agent worldwide. Globally, with every second, a
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Hydrogen peroxide and IL-18 pulmonary tuberculosis 575person is infected with Mycobacterium tuberculosis, how-
ever of those infected, 5–10% of them subsequently develop
the active disease during their life time.1
After inhalation, mycobacteria are internalized mainly by
alveolar macrophages, phagocytes then undergo respiratory
burst resulting in the production of capacious amounts of
reactive oxygen species (ROS) and nitrogen intermediates
(RNI). Incapable of decomposition by neither antioxidant
enzymes nor the conversion into hydroxyl radicals, hydrogen
peroxide (H2O2), which is generated by alveolar macro-
phages as well as type II pneumocytes in the lower
respiratory tract, can evaporate from the alveolar lining
fluid and then measured by expired breath condensate
(EBC). It has been well documented that increased levels of
H2O2 in EBC are associated with the inflammation in
bacterial, allergic (asthma) and autoimmune diseases
(sclerodermia).2–4 Previously, we revealed systemic oxida-
tive stress in patients with TB.5 Depending on the extent of
the disease serum concentration of lipid peroxidation
products (LPPs): conjugated dienes and malondialdehyde
were significantly elevated in patients with pulmonary TB.
Concentrations presented higher in patients with advanced
disease more so than in patients with only small radiographic
changes.
Although the exact mechanism of destroying M. tubercu-
losis is poorly understood, the interaction between T
lymphocytes and monocyte-derived macrophages through
the cytokines and cell-to-cell contacts are essential for
controlling the infection. Interferon-gamma (IFN-g) has been
shown to be a potent macrophage activator, which plays a
critical role in protective immunity. Interleukin-18 (IL-18)
originally defined as IFN-g inducing factor, exerts biological
functions analogous to that of IL-12 and promotes the
production of Th1 cytokines.6 On animal model Sugawara et
al.7 revealed that IL-18 deficient mice exhibited lower levels
of IFN-g than wild-types. It is noteworthy to mention that
considerable amounts of data indicate that IL-18 can
enhance oxidative stress. Mononuclear cells demonstrated
that IL-18 was able to stimulate the production of inducible
nitric oxide synthase, while exhibiting enhanced ROS
generation on melanoma cells.8,9 In light of increased
proportions in regards to the absolute number of neutrophils
and lymphocytes in bronchoalveolar fluid (BALF) along with
an elevated number of IFN-g mRNA positive cells (mainlyTable 1 Characteristic of study populations.
Parameters Patients with TB ðn ¼ 16Þ
Age (years) 42.5712.0
Sex (F/M) 5/11
Cumulative cigarette
consumption (pack-years)
1777
WBC 103 9.12272.109
Granulocytes 103 6.64072.127
Daily cigarette
consumption
2075
Extent of radiological
changes (pulmonary fields)
3.471.4lymphocytes),10,11 it was premised that markers of local
oxidative stress measured in EBC would be enhanced in
patients with pulmonary TB as well.
So the present study was undertaken to answer the three
questions: (1) Is the concentration of exhaled H2O2
increased in patients with TB compared with healthy
controls? (2) Is the level of exhaled H2O2 changed during
chemotherapy? and (3) Is there any correlation between
serum concentrations of IL-18 and the levels of exhaled H2O2
in patients with TB?Material and methods
Patients and study design
The study was conducted from January 2005 to April 2005.
The main study group consisted of 16 patients (mean age
42.5712 years, 5 women and 11 men), with pulmonary TB,
sputum smear and culture positive. All of them had: (1)
clinical manifestations of the disease like fever, night
sweats, weight loss and cough. Advanced changes were
evident on chest X-rays consisting of infiltrates or bronch-
opulmonary changes with cavities that covered 3.471.4
pulmonary zones. All patients were HIV-negative, current
cigarette smokers (smoking habits were not altered through-
out the study) without a history of other diseases (Table 1).
The patients were all treated with standard chemotherapy:
isoniazid 5mg kg1, rifampin 10mg kg1 (no more than
0.6 g day1), pyrazinamide 25mg kg1 and streptomycin
15mg kg1 (no more than 1 g day1) daily during the first 2
months followed by isoniazid 15mg kg1 and rifampin 0.6 g
twice a week for the next 4 months.
There are two peak values of exhaled H2O2 at 12 a.m. and
12 p.m.,12 hence EBC specimens were collected in patients
just before the introduction of chemotherapy as well as in
the control groups between 8 a.m. and 10 a.m. followed by
drawing 10ml of venous blood.
A chest X-ray examination as well as white blood cell
(WBC) and granulocyte counts were performed after 2
months of treatment.
The study consisted of two control groups of healthy
volunteers currently not on medication who did not suffer
from any respiratory disorders including any other diseases,Asymptomatic smokers
ðn ¼ 16Þ
Asymptomatic nonsmokers
ðn ¼ 17Þ
44.277.4 46.2715.4
4/12 6/11
1575 0
6.20070.550 5.84071.100
4.15071.010 3.85070.890
1573 0
0 0
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consisted of 16 cigarette smokers (mean age 44.277.4
years, 4 women and 12 men, cumulative cigarette con-
sumption 1575 pack-years), while group II, consisted of 17
nonsmokers (mean age 46.2715.4 years, 6 women and
11 men).
Protocol in this study was approved by the Ethics
Committee of the Medical University of Ło´dz´; also all
patients including healthy controls gave written informed
consent in participation of this study.Collection of EBC
The collection of EBC was executed as previously de-
scribed.13 The collecting device composed of a mouthpiece
that provided a one-way valve along with a saliva trap that
connected through a 50 cm tube to a glass Liebig tube cooler
(cooling and collecting tube measured 55 cm long, the
internal diameter measured 10mm and the external jacket
diameter measured 36mm; Labmed, Lodz, Poland cat no.
6010). The tube was cooled with ethanol, pumped in a
closed circuit and its temperature was then kept at 9 1C
with a Multi Temp III (Pharmacia, Biotech). Liquid EBC was
collected in the sterile plastic tube covered with ice
(Sarstedt, Numbvrecht, volume 13ml, internal diameter
14mm) mounted at the base of a Liebig tube cooler,
consistent with the previous temperature. Subjects were
asked to keep an invariable tidal breathing (respiratory rate
ranged from 17 to 23 breaths/min) during the 20min session
of EBC collection. Subject were given a nose clip, and before
each test were required to rinse their mouth with distilled
water and once again at 7 and 14min prior to collection. At
the end of test, 5–6ml aliquots of EBC were transferred to
Eppendorf tubes and stored at 80 1C for not more than 7
days until H2O2 measurement.0
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Figure 1 Concentration of H2O2 in EBC in patients with
pulmonary tuberculosis before treatment (TB), asymptomatic
cigarette smokers (SM) and asymptomatic nonsmokers (NSM):
*Po0:05 vs. SM, **Po0:05 vs. NSM ***Po05 vs. NSM.Measurement of H2O2 in EBC
Hydrogen peroxide concentrations were determined accord-
ing to the Ruch method14 with some modifications.15 Briefly,
600 ml of EBC was mixed with 600 ml of horseradish
peroxidase type II (HRP) solution (IU/ml) containing 100 mM
homovanilic acid and was incubated for 60min at 37 1C.
Then, the sample was mixed with 150 ml 0.1M glycine–NaOH
buffer (pH 12.0) with the addition of 25mM EDTA, and
emission at 420 nm after specimen excitation at 312 nm was
measured using a Perkin Elmer Luminescence Spectrometer
LS-50B (Norwalk, CT, USA). Readings were converted into mM
using the regression equation Y ¼ 0:012ðX  X0Þ  0:007
(where Y ¼ nanomoles of H2O2 per liter of EBC; X ¼ intensity
of emission at 420 nm expressed in arbitrary units;
X0 ¼ intensity of emission given by reference sample
receiving distilled water instead of EBC. The lower limit of
H2O2 detection was 83 nM. The intra-assay variability did not
exceed 2% for standard H2O2 solutions ranging from 0.1 to
0.5mM. Pre-incubation of EBC specimens ðn ¼ 4Þ with 20U of
catalase for 30min at 37 1C completely abolished the H2O2
signal.Measurement of IL-18 in serum
Concentration of IL-18 in serum was measured by enzyme-
linked immunosorbent assay (ELISA) using kits obtained from
MBL (Nagoya, Japan) according to the manufacturer’s
instructions. The absorbance was measured at 450 nm using
a microplate reader. The concentration of IL-18 was
calibrated from a dose response curve based on reference
standards. All assays were performed in duplicate. The
detectable range was between 12.5 and 1000 pg/ml.
Reagents
Horseradish peroxidase type II, catalase from Aspergillus
niger, and homovanilic acid were obtained from Sigma
Chemical Co. (St. Louis, MO, USA). EDTA and other reagents
were from POCh (Gliwice, Poland).
Statistical analysis
To perform statistical analysis Shapiro–Wilk test, t-test, U-
test, F-test and Pearson’s or Spearman correlation coeffi-
cient were used. All data were expressed as mean7-
standard deviation (SD). P value of o0:05 was considered
significant.
Results
Hydrogen peroxide in EBC
The highest concentration of H2O2 in EBC was observable in
patients with pulmonary TB before introduction of che-
motherapy—1.370.7 mM. The concentration was approxi-
mately three times higher than the result in healthy smokers
group ðPo0:001Þ (Fig. 1). After 2 months of treatment, the
concentration of H2O2 in EBC significantly decreased to
0.570.3mM and did not differ from that observed in the
healthy smokers group ðP40:05Þ, however concentration
remained significantly higher than in nonsmokers group
ðPo0:05Þ (Fig. 3) accompanied by a decrease in WBC
counts from 9.1272.1 103 to 7.5771.5 103/ml
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Hydrogen peroxide and IL-18 pulmonary tuberculosis 577ðPo0:05Þ, as well as granulocyte counts (6.6472.1 103
and 5.0371.4 103/ml, respectively, Po0:05).
Radiographic changes in patients with TB comprised
3.471.4 pulmonary fields at the beginning of the study
and after 2 months of treatment only 2.871.4 zones were
involved ðPo0:05Þ.
There were significant differences between the para-
meters assessing oxidative stress in healthy subjects.
Asymptomatic smokers (I control group) exhibited sig-
nificantly higher concentration of H2O2 in EBC than
never smoked subjects (II control group) (0.470.1 and
0.270.1 mM, respectively, Po0:05).Figure 3 Concentration of H2O2 and IL-18 in patients with
pulmonary tuberculosis during chemotherapy. -1 before intro-
duction of chemotherapy, -2 after 2 months of treatment:
*Po0:05 vs. H2O2-2, **Po0:05 vs. IL-18-2.
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Before introduction of antituberculous treatment, serum
concentration of IL-18 reached 787.67528.0 pg/ml, dimin-
ishing 2 months later to 400.67281.2 pg/ml ðPo0:05Þ,
however it remained significantly higher than that observed
in control groups ðPo0:05Þ (Figs. 2 and 3).
Serum IL-18 concentrations did not differ in asympto-
matic cigarette smokers and never smoked healthy volun-
teers (271.67114.9 and 229.9788.2 pg/ml, respectively,
P40:05).IL18 [pg/ml]
G
RA
NU
LO
CY
TE
 C
2
4
6
0 400 800 1200 1600 2000 2400
Figure 4 Correlation between serum concentration of IL-18
and neutrophil counts in patients with pulmonary TB before
chemotherapy: r ¼ 0:63, Po0:05.Correlations
There was a positive correlation between the serum
concentration of IL-18 and WBCs and neutrophil counts
before introduction of the chemotherapy (r ¼ 0:59 and 0.63,
respectively, Po0:05) (Fig. 4). Following 2 months of
treatment, IL-18 only correlated with WBC counts (r ¼ 0:5,
Po0:05).
There were no correlations between exhaled H2O2, WBC
counts, and granulocyte counts prior to, as well as
throughout chemotherapy among patients with TB. Patients
with TB also demonstrated no correlation between concen-
tration of exhaled H2O2 and serum level of IL-18 ðr ¼ 0:24,
P40:05Þ.0
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Figure 2 Serum concentration of IL-18 in patients with
pulmonary tuberculosis before treatment (TB), asymptomatic
cigarette smokers (SM) and nonsmokers (NSM): *Po0:05 vs. SM,
**Po0:05 vs. NSM.Discussion
To the best of our knowledge there is no documentation
concerning the concentration of H2O2 in EBC of patients with
TB. In the present study we have clearly demonstrated that
in patients with pulmonary TB, concentration of H2O2 in EBC
was significantly higher than that observed in cigarette
smokers. Measuring of H2O2 in EBC is a simple and
noninvasive method which can reflect the intensity of
inflammation and local oxidative stress in the airways. M.
tuberculosis belongs to the strong stimulators of respiratory
burst in human phagocytes, especially monocytes/macro-
phages. It is postulated that reactive oxygen and nitrogen
species are involved in the killing of mycobacteria. On an
animal model, Chan et al.16 reported that the inhibition of
nitric oxide (NO) production strongly aggravated mycobac-
terial infection in mice. MacMicking et al.17 described a
more rapid replication of M. tuberculosis in genetic mice
with an inability to produce inducible nitric oxide synthase
(iNOS) in comparison to wild type animals. Recently M.
tuberculosis induced iNOS expression was described in
human monocytes revealing that inhibition of NO production
resulted in the enhancement of intracellular mycobacterial
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patients with active pulmonary TB, finding that the cells
spontaneously generated higher amounts of RNI than those
from healthy controls.
Mycobacteria and cigarette smoke which both are known
to activate phagocytes, served as the two sources of
oxidants and free radicals in our patients with TB. One puff
of a cigarette smoke contained about 5 1014 free radicals12
while smoking one cigarette enhanced the level of H2O2 in
EBC approximately 1.8-fold.20 Recently, Szkudlarek et al.13
made known that healthy subjects, who never smoked,
exhaled detectible amounts of hydrogen peroxide, thus
catalyzing our investigation of control groups involving
smokers and nonsmokers.
After 2 months of antituberculous treatment, the level of
H2O2 in EBC significantly decreased and did not differ from
that in asymptomatic cigarette smokers, but was still higher
than in nonsmokers control group. In our study we confirm
the occurrence of local oxidative stress, which diminishes
during chemotherapy in patients with active pulmonary TB.
Our presented data shows consistency with the recent work
of Wang et al. who demonstrated elevated exhalation of NO
(marker of inflammation and oxidative stress) that regressed
to normal levels following 3 months of chemotherapy in
patients with active pulmonary TB.21
As the exact role of H2O2 in TB has not been clearly
established, increased concentration of hydrogen peroxide
in EBC may represent ongoing inflammation or be a
consequence of the host defense mechanism against
microbial invasion. Although there are conflicting data on
the role of RNI and ROS in TB infection, few epidemiological
studies shed light on this discrepancy. Recently, it has been
shown that the strains of M. tuberculosis which are RNI- and
ROS-resistant are responsible for the outbreak of the disease
in New York City and in the rural area near Kentucky and
Tennessee border.22,23
The investigation we undertook found no correlation
between the level of H2O2 in EBC as well as the extent of the
disease measured by the involved fields on X-ray. To our
opinion this may be due to homogeneity among our patients
all of whom presented with advanced TB with fever, night
sweats and cough. In our previous work5 systemic oxidative
stress depended on the extent of the disease, in view of
that, it was likely that patients with only minimal changes,
usually void of symptoms would exhale lower amount of
H2O2. Further studies are essential in the definitive
determination of the extent and role of ROS and RNI in TB
infection.
It is important to notice that chemotherapy itself may
influence the intensity of oxidative stress in TB patients.
Neutrophils obtained from healthy subjects incubated with
isoniazid produced significantly higher amounts of ROS; an
influence of pyrazinamide was not evident, while rifampin
was seen to inhibit chemiluminescence of cells.24 Also in
experimental animal Streptococcus pneumoniae-induced
meningitis, rifampin reduced production of ROS as compared
with beta-lactam antibiotics.25 Choi et al.26 recently
revealed that isoniazid strongly inhibited NADPH-dependent
microsomal production of ROS, thus initiating Walubo et
al.27 to investigate the administration of isoniazid, rifampin
and pyrazinamide in TB patients consequently resulting in
enhanced ROS production. Taking into account theseconflicting data, it is our strong suspicion that mycobacteria
may present as the main stimulator of oxidative burst in
patients with pulmonary TB. Accordingly, after 2 months of
chemotherapy, leading to the reduction of bacillus popula-
tion, concentration of H2O2 in EBC of TB patients who were
current smokers, demonstrated similarities to the value
observed in asymptomatic cigarette smokers.
We found that serum concentration of IL-18 in patients
with TB was significantly higher than in the controls,
conversely, as anticipated smokers and nonsmokers exhib-
ited a similar level of serum IL-18.
Our findings are in agreement with other studies.28,29
Yamada et al.28 found that the highest serum level of IL-18
was in patients with advanced TB, while in those with
minimal changes the result was the same as in healthy
controls. On the contrary to these results, Vankayalapati et
al.30 did not find the difference between serum concentra-
tions of IL-18 of TB patients and healthy PPD positive
controls.
IL-18, produced mainly by monocytes/macrophages and
dendritic cells, is considered to be one of the most
important cytokines in protective immunity. The levels of
this cytokine are especially elevated at the sites of
infection, i.e. pleural fluid or bronchoalveolar lavage
fluid.31–33
Although after 2 months of treatment serum concentra-
tion of IL-18 lowered ðPo0:5Þ, it was still significantly higher
than in the controls. Also Fujiuchi et al.34 reported gradually
decreasing serum level of IL-18 in TB patients, which was
higher even at the end of chemotherapy as compared to
healthy subjects.
It is interesting to note that this Th1 paradox—higher
concentrations of protective cytokines at the site of a
disease—does not prevent the disease. Conversely, despite
the elevated levels of IL-18 and IFN-g in the serum of TB
patients, peripheral blood mononuclear cells (PBMCs)
stimulated with mycobacterial antigens, produced signifi-
cantly lower amounts of IL-18 and IFN-g than in healthy
controls.30 Studing this problem, Fujiuchi et al.34 revealed
that the activity of the enzyme converting pro IL-18 into its
active form (interleukin-1 converting enzyme—ICE) was
impaired in patients with pulmonary TB. The authors
speculated that this might be the reason for reduced IFN-g
production from PBMCs in patients with TB. It is worth
mentoning that the levels of IL-18 were also increased in
PBMCs obtained from patients with chronic refractory TB,33
thus suggesting, IL-18 may perhaps play a role in the
prolonged survival of M. tuberculosis.
It is intriguing that in patients with TB serum concentra-
tion of IL-18 strongly correlated with WBC counts and
neutrophils, especially before the introduction of che-
motherapy. A number of experimental studies supported
our findings, particularly, Leung et al.35 who reported that
administration of IL-18 promoted neutrophil accumulation
and amplification the inflammation in vivo. This cytokine in
murine model attracted and activated neutrophils by
inducing the production of TNF-a, which in turn enhanced
the synthesis of leukotriene B4 (LTB4), a strong chemoat-
tractant for neutrophils.36 Furthermore, IL-18 induced LTB4,
is synthesized also by human peripheral blood neutrophils.36
Moreover, as revealed recently, IL-18 primed the oxidative
burst of neutrophils in response to formyl-peptides.37
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bridging innate and adoptive immune response.
In conclusion, we have documented the increased local
oxidative stress in patients with advanced pulmonary TB
measured by the level of exhaled H2O2. After 2 months of
chemotherapy, the level of exhaled H2O2 significantly
decreased and did not differ from the value observed in
asymptomatic smokers. In contrast, elevated serum con-
centration of IL-18 in patients with TB was higher than the
controls and did not correlate with exhaled H2O2 even after
2 months of antituberculous treatment.
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